Related Experiment Video
Updated: Sep 11, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
Multivalent interactions with CCR4-NOT and PABPC1 determine mRNA repression efficiency by tristetraprolin
Filip Pekovic1, Wi S Lai2, Joshua Corbo1
1National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Abstract:
Tristetraprolin family of proteins regulate mRNA stability by binding to specific AU-rich elements in transcripts. This binding promotes the shortening of the mRNA poly(A) tail, or deadenylation, initiating mRNA degradation. The CCR4-NOT complex plays a central role in deadenylation, while the cytoplasmic poly(A)-binding protein PABPC1 typically protects mRNAs from decay. Here, we investigate how tristetraprolin interacts with CCR4-NOT and PABPC1 to control mRNA stability. Using purified proteins and in vitro assays, we find that tristetraprolin engages CCR4-NOT through multiple interaction sites and promotes its activity, emphasizing the importance of multivalent binding for efficient deadenylation. Phosphorylation of tristetraprolin does not affect its interaction with CCR4-NOT or its deadenylation activity, but is essential for tristetraprolin's binding to PABPC1. We propose that tristetraprolin promotes the processive deadenylation activity of CCR4-NOT on mRNAs containing AU-rich elements, with phosphorylation-dependent interactions with PABPC1 potentially enhancing deadenylation and promoting regulated mRNA decay.
Insights
Tristetraprolin proteins control mRNA decay by interacting with the CCR4-NOT complex and PABPC1. Phosphorylation regulates these interactions, influencing mRNA stability and degradation.
Area of Science:
- Molecular Biology
- Gene Regulation
- Protein-RNA Interactions
Background:
- Tristetraprolin proteins bind AU-rich elements in mRNA to regulate stability.
- mRNA deadenylation, a key step in degradation, is mediated by the CCR4-NOT complex.
- Cytoplasmic poly(A)-binding protein PABPC1 typically protects mRNA from decay.
Purpose of the Study:
- To investigate the interaction mechanisms between tristetraprolin, CCR4-NOT, and PABPC1.
- To elucidate how these interactions control mRNA stability and degradation.
- To understand the role of tristetraprolin phosphorylation in these processes.
Main Methods:
- In vitro biochemical assays using purified proteins.
- Analysis of protein-protein interactions.
- Assessment of mRNA deadenylation and degradation rates.
Main Results:
- Tristetraprolin binds CCR4-NOT through multiple sites, enhancing its deadenylation activity.
- Tristetraprolin phosphorylation is not required for CCR4-NOT interaction or deadenylation.
- Phosphorylation is essential for tristetraprolin binding to PABPC1.
Conclusions:
- Tristetraprolin promotes processive deadenylation by CCR4-NOT on specific mRNAs.
- Phosphorylation-dependent PABPC1 interaction may further enhance deadenylation and regulated mRNA decay.
- This study reveals a complex regulatory mechanism for mRNA stability involving tristetraprolin family proteins.
Related Concept Videos
Co-activators and Co-repressors
Regulation of Expression at Multiple Steps
RNA Polymerase II Accessory Proteins
Cooperative Binding of Transcription Regulators
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Repressible Operon: trp Operon

